Literature DB >> 20525879

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Yun-Chu Wang1, Yu-Ling Chen, Ray-Hwang Yuan, Hung-Wei Pan, Wan-Ching Yang, Hey-Chi Hsu, Yung-Ming Jeng.   

Abstract

MicroRNAs (miRNAs) play critical roles in embryonic development and are frequently deregulated in human cancers. The let-7 family members are tumor-suppressing miRNAs and are frequently downregulated in cancer cells. Lin-28 and Lin-28B are RNA-binding proteins highly expressed in embryonic tissues. Lin-28 proteins block let-7 precursors from being processed to mature miRNAs by inducing terminal uridylation and degradation of let-7 precursors. Here, we report that Lin-28B, but not Lin-28, is highly expressed in hepatocellular carcinoma (HCC). Lin-28B expression was more frequently noted in high-grade HCCs with high alpha-fetoprotein levels. Knockdown of Lin-28B by RNA interference in the HCC cell line HCC36 suppressed proliferation in vitro and reduced in vivo tumor growth in NOD/SCID mice. In contrast, overexpression of Lin-28B in the HCC cell line HA22T enhanced tumorigenicity. Overexpression of Lin-28B also induced epithelial-mesenchymal transition in HA22T cells and hence, invasion capacity. Large-scale real-time PCR array analysis revealed that, among 380 miRNAs, only let-7/mir-98 family members were regulated by Lin-28B. Lin-28B overexpression enhanced the expression of the known let-7 targets c-myc and HMGA2. It was also found that Lin-28B enhanced the expression of type 1 insulin-like growth factor receptor in a let-7-dependent manner. These results indicate that Lin-28B regulates tumor formation and invasion in HCC through coordinated repression of the let-7/mir-98 family and induction of multiple oncogenic pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20525879     DOI: 10.1093/carcin/bgq107

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  57 in total

Review 1.  To polyadenylate or to deadenylate: that is the question.

Authors:  Xiaokan Zhang; Anders Virtanen; Frida E Kleiman
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

2.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

3.  MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs.

Authors:  Arun Bhardwaj; Seema Singh; Ajay P Singh
Journal:  Mol Cell Pharmacol       Date:  2010

4.  MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box.

Authors:  Zifeng Wang; Sheng Lin; Julia Jun Li; Zhenhua Xu; Hong Yao; Xiao Zhu; Dan Xie; Zan Shen; Johnny Sze; Kui Li; Gang Lu; Danny Tat-Ming Chan; Wai Sang Poon; Hsiang-fu Kung; Marie Chia-mi Lin
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

5.  MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication.

Authors:  Wen-Wen Chou; Chung-Feng Huang; Ming-Lun Yeh; Yi-Shan Tsai; Ming-Yen Hsieh; Ching-I Huang; Jee-Fu Huang; Pei-Chien Tsai; Edward Hsi; Suh-Hang Hank Juo; Wei-Lun Tsai; Wan-Long Chuang; Ming-Lung Yu; Chia-Yen Dai
Journal:  J Mol Med (Berl)       Date:  2015-10-21       Impact factor: 4.599

6.  A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.

Authors:  Robert W Schnepp; Priya Khurana; Edward F Attiyeh; Pichai Raman; Sara E Chodosh; Derek A Oldridge; Maria E Gagliardi; Karina L Conkrite; Shahab Asgharzadeh; Robert C Seeger; Blair B Madison; Anil K Rustgi; John M Maris; Sharon J Diskin
Journal:  Cancer Cell       Date:  2015-10-17       Impact factor: 31.743

7.  A LIN28B polymorphism predicts for colon cancer survival.

Authors:  Yuanqing Ye; Blair Madison; Xifeng Wu; Anil K Rustgi
Journal:  Cancer Biol Ther       Date:  2012-10-10       Impact factor: 4.742

8.  Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.

Authors:  Elena Piskounova; Christos Polytarchou; James E Thornton; Robert J LaPierre; Charalabos Pothoulakis; John P Hagan; Dimitrios Iliopoulos; Richard I Gregory
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

9.  MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.

Authors:  Heping Yang; Michele E Cho; Tony W H Li; Hui Peng; Kwang Suk Ko; Jose M Mato; Shelly C Lu
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

10.  LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.

Authors:  Jan J Molenaar; Raquel Domingo-Fernández; Marli E Ebus; Sven Lindner; Jan Koster; Ksenija Drabek; Pieter Mestdagh; Peter van Sluis; Linda J Valentijn; Johan van Nes; Marloes Broekmans; Franciska Haneveld; Richard Volckmann; Isabella Bray; Lukas Heukamp; Annika Sprüssel; Theresa Thor; Kristina Kieckbusch; Ludger Klein-Hitpass; Matthias Fischer; Jo Vandesompele; Alexander Schramm; Max M van Noesel; Luigi Varesio; Frank Speleman; Angelika Eggert; Raymond L Stallings; Huib N Caron; Rogier Versteeg; Johannes H Schulte
Journal:  Nat Genet       Date:  2012-10-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.